Annual report pursuant to Section 13 and 15(d)

Related Party Transactions (Details)

v3.22.1
Related Party Transactions (Details)
 12 Months Ended
Nov. 05, 2020
shares
Dec. 31, 2021
USD ($)
Officer
Director
BoardMember
shares
Apexian Sublicense Agreement [Abstract]    
Common stock issued (in shares) 7,091,878  
Waiver Agreements [Abstract]    
Number of directors signed waiver agreements | Director   6
Apexian Sublicense Agreement [Member]    
Apexian Sublicense Agreement [Abstract]    
Common stock issued (in shares)   843,751
Apexian Sublicense Agreement [Member] | Common Stock [Member]    
Apexian Sublicense Agreement [Abstract]    
Common stock issued (in shares)   843,751
Pre-Merger Financing [Member]    
Pre-Merger Financing [Abstract]    
Amount invested in pre-merger financing | $   $ 300,000
Number of converted initial shares received by directors (in shares)   17,729
Number of converted additional shares (in shares)   53,189
Pre-Merger Financing [Member] | Private Ocuphire [Member]    
Pre-Merger Financing [Abstract]    
Number of directors | Director   5
Pre-Merger Financing [Member] | Rexahn [Member]    
Pre-Merger Financing [Abstract]    
Number of directors | Director   1
Pre-Merger Financing [Member] | Series A Warrants [Member]    
Pre-Merger Financing [Abstract]    
Number of converted additional shares (in shares)   80,366
Pre-Merger Financing [Member] | Series B Warrants [Member]    
Pre-Merger Financing [Abstract]    
Number of converted additional shares (in shares)   9,444
Convertible Notes [Member]    
Convertible Notes with Related Parties [Abstract]    
Aggregate amount of convertible notes issue to board and officers | $   $ 700,000
Number of board members | BoardMember   4
Number of officers | Officer   2
Number of officers also a board member | BoardMember   1